Myriad Group AG Bundle
Who Really Owns Myriad Group AG?
Unraveling the ownership structure of a company is crucial for understanding its strategic maneuvers and future prospects. Myriad Group AG, a Swiss company specializing in mobile services, presents a compelling case study in corporate ownership dynamics. Understanding Myriad Group AG SWOT Analysis is essential for investors and strategists.
From its inception in 1999 as Esmertec AG to its 2009 merger with Purple Labs, Myriad Group AG's evolution has been marked by significant shifts in its ownership. This exploration of Myriad company ownership will examine the major shareholders, providing insights into the company's strategic direction and financial performance. We'll delve into the details of who owns Myriad, offering a comprehensive look at Myriad Group AG's investor relations and the factors influencing its stock price history.
Who Founded Myriad Group AG?
The story of Myriad Group AG begins with Esmertec AG, which was established in 1999. However, the entity as it is known today emerged in 2009, following a merger with Purple Labs.
Purple Labs, a key piece of Myriad's history, was founded in 2001. The founders included Jean-Luc Botto, Dennis O'Donovan, Sebastien Soyer, and Jean-Marie Andre. The company's base of operations was in Chambéry, France.
Purple Labs played a significant role in the mobile technology sector. It focused on creating and distributing Linux-based software. This software was aimed at mobile Original Equipment Manufacturers (OEMs) and Original Design Manufacturers (ODMs).
Esmertec's Foundation
Esmertec AG was incorporated in 1999, marking the initial phase of what would become Myriad Group AG. This early start laid the groundwork for future developments in mobile software solutions.
Purple Labs' Origins
Purple Labs was founded in 2001 by a team including Jean-Luc Botto, Dennis O'Donovan, Sebastien Soyer, and Jean-Marie Andre. Their focus was on Linux-based software for mobile devices.
The Merger in 2009
The merger between Esmertec AG and Purple Labs in 2009 was a pivotal moment. This consolidation led to the formation of the Myriad Group AG as it is currently known.
Software Focus
Both Esmertec and Purple Labs were driven by the vision of providing software solutions. These solutions were designed to enhance connectivity and functionality across various mobile devices and platforms.
Early Strategies
The strategies of both companies were centered on the evolving needs of the mobile communication landscape. This approach allowed them to adapt and grow within a dynamic market.
Key Personnel
The founders of Purple Labs, including Jean-Luc Botto and others, played crucial roles. Their expertise and leadership were instrumental in shaping the company's direction.
Specific details such as the initial equity distribution among the founders or the involvement of early investors in either Esmertec AG or Purple Labs are not readily available. Information on aspects like vesting schedules, buy-sell agreements, or any initial ownership disputes that may have influenced the early ownership structure is also limited. For more insights, you might find further details in an article discussing the history of Myriad Group AG.
Key Takeaways
Understanding the early ownership and the merger that created Myriad Group AG provides context. It helps to grasp the company's evolution and its strategic focus on mobile software solutions.
- The foundation of Myriad Group AG stems from Esmertec AG's incorporation in 1999.
- Purple Labs, founded in 2001, contributed significantly to the company's development.
- The merger in 2009 marked a crucial turning point, shaping the company's current identity.
- Both companies aimed to provide software solutions for mobile devices.
- Details on early ownership structures and investor involvement are not readily accessible.
Myriad Group AG SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Myriad Group AG’s Ownership Changed Over Time?
The ownership of Myriad Group AG has evolved significantly since its formation in 2009 through the merger of Purple Labs and Esmertec. The company, which has a status of 'Acquired/Merged' according to PitchBook, has secured $54.5 million in funding across seven rounds. The initial market capitalization post-merger isn't readily available. Understanding the current ownership structure requires distinguishing between Myriad Group AG and Myriad Genetics, Inc., a publicly traded company in genetic testing.
As of May 12, 2025, Myriad Group AG's market capitalization was £15.45 million. While Myriad Group AG is listed on the Swiss stock market (MYRN) as of June 12, 2025, the available data primarily concerns Myriad Genetics, Inc. (NASDAQ: MYGN). Myriad Genetics, Inc. has substantial institutional ownership, with 499 institutional owners holding a total of 113,716,015 shares. Key shareholders include BlackRock, Inc., Vanguard Group Inc, and State Street Corp. Myriad Genetics, Inc. had 90,600,000 shares outstanding as of April 2025. The distinction between the two entities is crucial when analyzing ownership and financial information.
| Key Event | Date | Impact on Ownership |
|---|---|---|
| Merger of Purple Labs and Esmertec | 2009 | Formation of Myriad Group AG, initial ownership structure established. |
| Funding Rounds | Various | Dilution of ownership through the issuance of new shares to investors. |
| Listing on Swiss Stock Market | June 12, 2025 | Potential for public trading of shares, impacting the shareholder base. |
The available information doesn't offer specific details about the current major stakeholders of Myriad Group AG (the software company). This includes the founders' remaining stakes, specific venture capital or private equity firms, or significant individual shareholders post-merger and any subsequent acquisitions. For more insights into the company's strategic direction, you might find the Growth Strategy of Myriad Group AG article helpful.
Key Takeaways on Myriad Company Ownership
The ownership structure of Myriad Group AG is complex, requiring careful distinction between the software company and Myriad Genetics, Inc.
- Myriad Group AG is listed on the Swiss stock market.
- Myriad Genetics, Inc. has significant institutional ownership.
- Specific details on Myriad Group AG's current major shareholders are limited.
- Understanding Myriad shareholders requires differentiating between the two entities.
Myriad Group AG PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Myriad Group AG’s Board?
Information regarding the current board of directors of Myriad Group AG is not available in the provided search results. The available information primarily pertains to Myriad Genetics, Inc., a distinct entity. For Myriad Genetics, Inc., the Board of Directors appointed Sam Raha as President and Chief Executive Officer and a board member, effective April 30, 2025. S. Louise Phanstiel is the Chair of Myriad Genetics' Board of Directors.
Details on the voting structure of Myriad Group AG, such as one-share-one-vote, dual-class shares, or other arrangements, are not specified. Similarly, there is no information about individuals or entities with outsized control due to special voting rights, golden shares, or founder shares for Myriad Group AG. No recent proxy battles, activist investor campaigns, or governance controversies related to Myriad Group AG were found in the provided search results. For further insights into the company's operations, you might find it helpful to explore Revenue Streams & Business Model of Myriad Group AG.
| Aspect | Details | Status |
|---|---|---|
| Board of Directors | Information not available for Myriad Group AG. | N/A |
| Voting Structure | Details on voting rights not specified. | N/A |
| Major Shareholders | Information on major shareholders not available. | N/A |
Myriad Group AG Board and Ownership Overview
The current board composition and specific ownership details for Myriad Group AG are not readily available. This includes information about which members represent major shareholders or founders. The voting structure and any special voting rights are also unspecified.
- No details on board members representing major shareholders are available.
- Voting structure details, such as one-share-one-vote, are not provided.
- No information on recent proxy battles or governance controversies.
- Further research into Myriad financial information may provide additional insights.
Myriad Group AG Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Myriad Group AG’s Ownership Landscape?
Recent developments for Myriad Group AG indicate a focus on providing software solutions. In 2024, the company's revenues reached $1.7 million. The company's strategy includes providing software solutions for device manufacturers, operators, and consumers. Direct sales contributed 60% of Myriad's revenue, while indirect sales accounted for 35%.
For Myriad Genetics, Inc., significant changes occurred in 2024 and early 2025. The company reported total revenues of $211 million in Q4 2024, a 7% year-over-year increase. Full-year 2024 revenue reached $838 million, an 11% increase over 2023. Myriad Genetics, Inc. also announced a leadership transition, with Sam Raha appointed as President and CEO effective April 30, 2025.
| Metric | Myriad Group AG | Myriad Genetics, Inc. |
|---|---|---|
| 2024 Revenue | $1.7 million | $838 million |
| Q4 2024 Revenue (YoY) | N/A | +7% |
| Cash and Cash Equivalents (Dec 31, 2024) | N/A | Approximately $102 million |
The global embedded software market, relevant to Myriad Group AG's core business, was valued at $197.3 billion in 2024 and is projected to reach $282.3 billion by 2029. This growth indicates a promising market for the company. To understand more about the strategic direction of Myriad Group AG, consider exploring the Growth Strategy of Myriad Group AG.
Myriad Group AG's Revenue
Myriad Group AG reported $1.7 million in revenue for 2024. This figure highlights the company's financial performance. The revenue is from providing software solutions.
Myriad Genetics, Inc. Financials
Myriad Genetics, Inc. saw $838 million in revenue for 2024. This represents an 11% increase. The company's cash and cash equivalents were approximately $102 million.
Market Growth
The embedded software market was worth $197.3 billion in 2024. It is expected to reach $282.3 billion by 2029. This growth shows opportunities for Myriad Group AG.
Leadership Changes
Sam Raha will become President and CEO of Myriad Genetics, Inc. on April 30, 2025. Mark S. Verratti was promoted to COO. These changes reflect the company's evolving strategy.
Myriad Group AG Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Myriad Group AG Company?
- What is Competitive Landscape of Myriad Group AG Company?
- What is Growth Strategy and Future Prospects of Myriad Group AG Company?
- How Does Myriad Group AG Company Work?
- What is Sales and Marketing Strategy of Myriad Group AG Company?
- What is Brief History of Myriad Group AG Company?
- What is Customer Demographics and Target Market of Myriad Group AG Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.